CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

WEST PHARMACEUTICAL SERVICES INC

WST
$23.17B
Large Cap
NASDAQSurgical & Medical Instruments & ApparatusMedical devices🇺🇸North AmericaEXTON8.2K employees

West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. Founded in 1923 by Herman O. West and J.R. Wike of Philadelphia, the company is headquartered in Exton, Pennsylvania. In its early years of development, West produced rubber components for packaging injectable drugs, providing a sterile environment for the producers of penicillin and insulin.

Website

Drugs in Pipeline

5

Phase 3 Programs

2

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

WST News
Catalyst Timeline

0 upcoming, 1 past

No catalysts found.

How WST's past catalysts played out

Drug Pipeline
Market-Implied Move
Regulatory Approvals

Frequently asked questions

What is in WEST PHARMACEUTICAL SERVICES INC's drug pipeline?

CatalystAlert tracks 5 drug candidates in WEST PHARMACEUTICAL SERVICES INC's (WST) pipeline across Phase 3, Phase 2. Its lead program is Morphine Sulfate (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is WEST PHARMACEUTICAL SERVICES INC's next FDA catalyst?

CatalystAlert tracks every upcoming catalyst for WEST PHARMACEUTICAL SERVICES INC (WST) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track WST biotech catalysts?

Add WST to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow WEST PHARMACEUTICAL SERVICES INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply